Table S5. Haematological parameters.
| Parameter | G1 | G2 | G3 | G4 | G5 | G6 | G7 | ||
|---|---|---|---|---|---|---|---|---|---|
| N(WBC)/(103/μL) | 5.8±1.1 | 3.8±1.1 | 4.6±1.1 | 4.7±1.5 | 4.6±0.8 | 3.7±0.8 | 4.6±0.4 | ||
| N(RBC)/(106/μL) | 10.7±1.5 | 12.7±0.7 | 12.6±1.5 | 12.2±0.5 | 11.4±1.7 | (10.7±0.8)a | 10.8±1.0 | ||
| γ(Hb)/(g/100 mL) | (14.4±1.9)a | 17.3±0.6 | 16.1±2.1 | 16.0±0.5 | 15.4±2.2 | (14.6±1.0)a | (14.5±1.5)a | ||
| w((HCT)/% | 52.3±7.3 | 61.4±3.2 | 61.1±7.3 | 58.8±2.3 | 54.72±8.18 | 51.56±4.03 | 51.74±5.23 | ||
| N(PLT)/(103/μL) | 1377±286 | 768±145 | 1165±234 | 1224±266 | 1501±114 | 1464±188 | 1551±15 | ||
| V(MC)/µm3 | 49.0±0.0 | 48.4±0.6 | 48.2±0.5 | 48.4±0.6 | 47.8±0.5 | 48.2±0.5 | 48.2±0.8 | ||
| m(MCH)/pg | 13.4±0.2 | 13.7±0.3 | (12.7±0.5)a | 13.2±0.2 | 13.7±0.2 | 13.7±0.2 | 13.9±0.9 | ||
| γ(MCHC)/(g/dL) | 27.7±0.4 | 28.2±0.5 | (26.3±0.9)a | (27.2±0.4)a | 28.1±0.3 | 28.4±0.4 | 28.0±0.3 | ||
| w(NEU)/% | 23.6±2.2 | 26.0±4.0 | 27.6±3.6 | 24.0±2.8 | 26.0±2.8 | 28.8±3.6 | 25.6±3.3 | ||
| w(LYM)/% | 70.4±2.6 | 69.6±3.3 | 69.6±1.7 | 72.0±2.0 | 70.0±1.4 | 67.6±2.2 | 69.2±1.1 | ||
| w(EOS)/% | 2.8±0.9 | 2.2±0.8 | 1.2±1.1 | 1.4±1.1 | 3.0±1.9 | 1.8±0.8 | 2.2±1.3 | ||
| w(MON)/% | 3.2±0.8 | 2.2±0.8 | 1.6±1.3 | 2.6±1.1 | 3.0±1.9 | 1.8±1.3 | 3.0±1.9 | ||
| w(BAS)/% | 0.00±0.00 | 0.00±0.00 | 0.00±0.00 | 0.00±0.00 | 0.00±0.00 | 0.00±0.00 | 0.00±0.00 | ||
Values are expressed as mean±standard deviation (N=10). aIndicates statistically significant differences (p<0.05) with respect to G2. G1=normal control, G2=HFD control, G3=HFD+capsanthin-enriched pellets (low dose), G4=HFD+capsanthin-enriched pellets (medium dose), G5=HFD+capsanthin-enriched pellets (high dose), G6=HFD+capsaicin pellets, G7=HFD+orlistat, HFD=high fat diet, WBC=total leukocyte count, RBC=erythrocyte count, Hb=haemoglobin, HCT=haematocrite, PLT=platelet, MC=mean corpuscular, MCH=mean corpuscular haemoglobin, MCHC=mean corpuscular haemoglobin concentration, NEU=neutrophils, LYM=lymphocytes, EOS=eosinophils, MON=monocytes, BAS=basophils